-+ 0.00%
-+ 0.00%
-+ 0.00%

Canaccord Genuity Maintains Hold on Veracyte, Lowers Price Target to $40

Benzinga·04/20/2026 16:19:02
Listen to the news
Canaccord Genuity analyst Kyle Mikson maintains Veracyte (NASDAQ:VCYT) with a Hold and lowers the price target from $43 to $40.